EXOLIN
LIVE

Serial Number

79216396

Owner

DEFYMED

Attorney

Andrew W. Chu

Filing Date

Jun 8, 2017

Add to watchlist:

No watchlists yet
View on USPTO

EXOLIN Trademark

Serial Number: 79216396 • Registration: 5477924

EXOLIN is a trademark filed by DEFYMED on June 8, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

DEFYMED (3 trademarks)

9 rue Albert Calmette

Entity Type: 99

Trademark Details

Filing Date

June 8, 2017

Registration Date

May 29, 2018

Published for Opposition

March 13, 2018

Cancellation Date

December 13, 2024

Goods & Services

Surgical and medical apparatus and instruments for use in implanting insulin injectors; catheters; implantable devices for the subcutaneous release of medicated substances sold empty; surgical implants comprised of artificial materials; vacuum pumps for medical use; injector devices for medical use in delivering pharmaceuticals

Conducting clinical trials for others in the fields of medical devices and pharmaceuticals; research and development of new products for others; research and development in the field of bioartificial medical devices; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; biological research services; bacteriological research services; chemical research; scientific research; technical research in the field of pharmaceutical studies; services provided by consultants relating to scientific research and development in the field of therapeutics; scientific laboratory services

Cultures of microorganisms for medical or veterinary use; biological tissue cultures for medical or veterinary use; enzymes for medical or veterinary use; vascular grafts of living tissues; hormones for medical use; surgical implants composed of living tissue; medicines for intestinal disorders in humans; biological preparations for medical or veterinary use in treating metabolic disorders; chemical-pharmaceutical preparations for the treatment of diabetes; chemical preparations for medical or veterinary use for the treatment of diabetes; chemical preparations for pharmaceutical use in the treatment of diabetes; preparations of microorganisms for medical and veterinary use in the treatment of diabetes; diagnostic preparations for medical or veterinary use

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Feb 19, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 1, 2026 INTS
INVALIDATION PROCESSED
Feb 1, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 13, 2025 INTR
CANCELLED SECTION 71
Dec 13, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 29, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 11, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 11, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2018 CRFA
ASSIGNED TO LIE
Jan 25, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2018 TROA
REFUSAL PROCESSED BY IB
Oct 14, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 22, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 22, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 22, 2017 RFCR
NON-FINAL ACTION WRITTEN
Sep 21, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 19, 2017 MAFR
ASSIGNED TO EXAMINER
Sep 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 14, 2017 REPR